HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

Deeks, S. G, Phillips, A. N·2009·BMJ
DOI 10.1136/bmj.a3172

Cited by (702)

Items 501–600 of 702

  1. PERCEPTION OF VULNERABILITY TO HIV INFECTION AMONG OLDER PEOPLE IN NAIROBI, KENYA: A NEED FOR INTERVENTION
    Gloria Chepngeno‐Langat · 2012 · Journal of Biosocial Science
  2. Optimal antiretroviral therapy for aging
    Damien V. Cordery, David A. Cooper · 2011 · Sexual Health
  3. Screening of HIV-infected patients for non-AIDS-related morbidity: an evidence-based model of practice
    Rosalind Foster, Sian Morris, Nathan Ryder, Lynne Wray, Anna M. McNulty · 2011 · Sexual Health
  4. HIV-Infected Men with an Elevated Level of Serum Cystatin C have a High Likelihood of Developing Cancers
    Naoki Yanagisawa, Minoru Ando · 2012 · Journal of Antivirals & Antiretrovirals
  5. Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana
    Michael J. A. Reid, Michelle K. Haas, Pinkie Sedigeng, Doreen Ramogola‐Masire, Harvey M. Friedman, Ari Ho Foster · 2015 · Journal of the International Association of Providers of AIDS Care (JIAPAC)
  6. The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study
    Huiting Ma, Conrado Franco‐Villalobos, Martin St‐Jean, Oghenowede Eyawo, Miriam Ruth Lavergne, Lianping Ti, Mark Hull, Benita Yip, Lang Wu, Robert S. Hogg et al. · 2018 · BMC Health Services Research
  7. Cognitive impairment among older adults living with HIV/AIDS and frailty
    Alfonso Zamudio‐Rodríguez, Sara G. Aguilar-Navarro, José Alberto Ávila‐Funes · 2018 · Gaceta Médica de México
  8. Review of electrocardiographic abnormalities among people living with HIV in Sub-Saharan Africa: A systematic review
    Andrew Weil Semulimi, Andrew Peter Kyazze, Edward Kyalo, John Mukisa, Charles Batte, Felix Bongomin, Isaac Ssinabulya, Bruce Kirenga, Emmy Okello · 2023 · PLoS ONE
  9. HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study
    Tao Yang, Zhiman Xie, Zhe Xu, Bo Tu, Huan Lu, Huihuang Huang, Lei Huang, Chao Zhang, Liying Gao, Lei Jin et al. · 2024 · Emerging Microbes & Infections
  10. Ophthalmologic manifestations of elderly patients with human immunodeficiency virus infection
    Annamaria Ciminelli Barbosa, Renato Sztern Queiroz, Giovanni Nicola Umberto Italiano Colombini, Arlindo José Freire Portes, Walter de Araújo Eyer-Silva · 2019 · Revista Brasileira de Oftalmologia
  11. Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?
    Yasbanoo Moayedi, Sharon Lynn Walmsley · 2019 · The Journal of Infectious Diseases
  12. HIV and Aging: Parallels and Synergistic Mechanisms Leading to Premature Disease and Functional Decline
    Anna C. Hearps, Katherine R. Schafer, Kevin P. High, ALAN L. LANDAY · 2015 · Springer eBooks
  13. Utilizing the Mol2Vec Algorithm to Extract Features of HIV Drug Interactions
    Felix Indra Kurniadi, Risma Yulistiani · 2024 · International Conference on Artificial Intelligence and Data Sciences (AiDAS)
  14. HIV but Not CMV Replication Alters the Blood Cytokine Network during Early HIV Infection in Men
    Christophe Vanpouille, Alan Wells, Jennifer M. Dan, Stephen A. Rawlings, Susan J. Little, Wendy Fitzgerald, Leonid B Margolis, Sara Gianella · 2022 · Viruses
  15. Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases
    Ana K. Villagómez‐Guzmán, Israel Valencia Quiroz · 2024 · Recent advances in biotechnology
  16. A prospective cohort study of the SEARCH integrated HIV/hypertension community health worker‐led intervention in rural Kenya and Uganda
    Matthew D. Hickey, Asiphas Owaraganise, Sabina Ogachi, Helen Sunday, Colette Aoko, Norton Sang, George Agengo, Jane Kabami, Elijah Ronald Kakande, Erick Mugoma Wafula et al. · 2025 · Journal of the International AIDS Society
  17. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer‐free, HIV‐1–infected patients
    Vincenzo Spagnuolo, Giovanna Travi, Laura Galli, Francesca Cossarini, Monica Guffanti, Nicola Gianotti, Stefania Salpietro, Adriano Lazzarin, Antonella Castagna · 2013 · Cancer
  18. Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda
    Ekwaro Anthony Obuku, Sujal M. Parikh, Victoria Nankabirwa, Nelson Kakande, David Kaawa Mafigiri, Harriet Mayanja‐Kizza, Cissy M Kityo, Peter N. Mugyenyi, Robert A. Salata · 2013 · PLoS ONE
  19. Transplantation of the Patient with Human Immunodeficiency Virus
    Kyle R. Jackson, Andrew MacGregor Cameron · 2017 · Advances in Surgery
  20. Changes in multimorbidity burden over a 3–5 year period among people with HIV
    Luxsena Sukumaran, Davide De Francesco, Alan Winston, Patrick W. G. Mallon, Nicki Doyle, Jane Anderson, Marta Boffito, Ian G. Williams, Frank A. Post, Jaime H. Vera et al. · 2023 · Frontiers in Systems Biology
  21. Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
    Ryan Yucha, Morgan L. Litchford, Carolyn S. Fish, Zak A. Yaffe, Barbra A. Richardson, Elizabeth Maleche‐Obimbo, Grace C. John-Stewart, Dalton C. Wamalwa, Julie M. Overbaugh, Dara A. Lehman · 2023 · Viruses
  22. The V-BRCH Project: Strengthening HIV Research Capacity in Nigeria through Intensive Workshops in Implementation Science and Grant Writing
    Kevin M Gibas, Aima A. Ahonkhai, Alexander Huang, Chelsea van Wyk, Fatimah Isma’il Tsiga-Ahmed, Baba Maiyaki Musa, Mahmoud U. Sani, Carolyn Marie Audet, C. William Wester, Muktar Hassan Aliyu · 2024 · American Journal of Tropical Medicine and Hygiene
  23. Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling
    Helen Tracey, Simon T. Bate, Susan L. Ford, Parul Patel, Jackie C. Bloomer, Aarti H. Patel, Kunal S. Taskar · 2025 · Pharmaceutics
  24. Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus
    Werimo Pascal Kuka, Jasmit Shah, Uazman Alam, Reena Shah, Dilraj Singh Sokhi · 2022 · Diabetes Therapy
  25. Untreated HIV: harmful even at high CD4 cell counts
    Ingrid Valerie Bassett, Paul Edward Sax · 2010 · The Lancet
  26. Decision making in non-AIDS-defining malignancies
    David Michael Aboulafia · 2012 · The Lancet Oncology
  27. Smoking Behaviour Among People Living with HIV and AIDS: A Sub-Group Comparison.
    Kate Babineau, S O'Dea, Grainne Courtney, Luke Clancy · 2016 · PubMed
  28. Pulmonary Complications of HIV Infection
    Alison Morris, Kristina A. Crothers, Laurence Huang · 2016 · Seminars in Respiratory and Critical Care Medicine
  29. Second European Round Table on the Future Management of HIV
    Casper Rokx, Douglas D. Richman, Michaela C. Müller-Trutwin, Guido Silvestri, Jan van Lunzen, Saye Khoo, Mathias D. Lichterfeld, Marcus A. Altfeld, Carlo Federico Perno, Peter W. Hunt et al. · 2015 · Journal of Virus Eradication
  30. The Case Series of 34 Patients with COVID-19 Diagnosed with HIV Infection from Central and Eastern European Countries – Euroguidelines in Central and Eastern Europe Network Group Data
    Agata Skrzat‐Klapaczyńska, Kerstin Kase, Anna Vassilenko, Arjan Harxhi, Botond Lakatos, Gordana Dragović, David Jilich, Antonija Verhaz, Nina Yancheva, Florentina Dumitrescu et al. · 2020
  31. The role of HAART in mitigating neurocognitive decline among HIV-positive Africans: Systematic review and meta-analysis
    Mulualem Admasu Kelebie, Getasew Kibralew, Gebresilassie Tadesse, Girum Nakie, Mulu Muche, Dawed Ali, Birtukan Fasil, Gidey Rtbey, Biruk Fanta, Nega Gedefaw Agmase et al. · 2025 · Comprehensive Psychiatry
  32. Health-Related Quality of Life in Well-treated People With HIV and Comparators Over an 8-year Period: A Longitudinal Analysis From the Prospective AGEhIV Cohort Study
    Kevin Moody, Manon C. Vanbellinghen, Pythia T. Nieuwkerk, Anders C. Boyd, Maarten F. Schim van der Loeff, Suzanne E. Geerlings, Peter Reiss, Marc van der Valk, AGEhIV study group, Peter Reiss et al. · 2026 · Clinical Infectious Diseases
  33. Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapy
    Luis Furuya‐Kanamori, Mark D. Kelly, Samantha J. McKenzie · 2015 · Sexual Health
  34. Non-AIDS Morbidity among HIV Patients
    Shin‐Woo Kim · 2016 · Korean Journal of Medicine
  35. Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d’Ivoire, West Africa: A cross-sectional study
    Mariam Mama Djima, Didier Koumavi Ekouévi, Jean‐Pierre Grégoire, Boris Tchounga, Patrick Ahuatchi Coffie, Viet-Thi Tran, Franck Y. Touré, Jocelyne Moisan · 2019 · PLoS ONE
  36. Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study
    Ruxandra-Cristina Marin, SIMONA GABRIELA BUNGAU, Delia Mirela Ţiţ, Paul Andrei Negru, Andrei-Flavius Radu, Radu Dumitru Moleriu · 2023 · Biomedicine & Pharmacotherapy
  37. Prevalence of mental distress and factors associated with symptoms of major depression among people living with HIV in Norway
    Vegard Skogen, Ranveig Langseth, Gudrun Elin Rohde, Ole Rysstad, Tore Sørlie, Birgit Lie · 2023 · AIDS Care
  38. HIV infection and ART use are associated with altered plasma clot characteristics in Black South Africans
    Shams Bakali, Zelda de Lange, Anine Jordaan, Marlien Pieters · 2024 · PLoS ONE
  39. Determining the Factors Affecting the Survival of HIV Patients: Comparison of Cox Model and the Random Survival Forest Method
    Nasim Karimi, Maliheh Safari, Mohammad Mirzaei, Amir Kasaeian, Ghodratollah Roshanaei, Tahereh Omidi · 2019 · International Electronic Journal of Medicine
  40. SCIENTIFIC RESEARCH ON THE RISK OF THE SEXUAL TRANSMISSION OF HIV INFECTION AND ON HIV AS A CHRONIC MANAGEABLE INFECTION
    Rupert Kaul · 2011
  41. A Service Delivery Model for Addressing Activity and Social Participation Needs of People Living with HIV
    Gayle J. Restall, Theresa Sullivan, Tara Carnochan, Emily Etcheverry, Kerstin Roger, Pumulo Roddy · 2017 · The Open Journal of Occupational Therapy
  42. HIV pharmacogenetics and pharmacogenomics: From bench to bedside
    Sophie Limou, Cheryl Ann Winkler, C. William Wester · 2019 · Elsevier eBooks
  43. Body Burden of Lead, Cadmium and Vanadium among HIV Patients on Antiretroviral Drugs in Port Harcourt, Niger Delta, Nigeria
    Ifeyinwa Nwogo Chijioke-Nwauche, Sydney Yakubu, Ndidiamaka Obasi, Sordum Nboi · 2020 · Saudi Journal of Medical and Pharmaceutical Sciences
  44. Care Outcomes in People Living with HIV and Cancer
    Kareshma Mohanty, Helen W. Cheung, Kristen A. Stafford, David James Riedel · 2021 · Current treatment options in infectious diseases/Current treatment options in infectious disease
  45. Racial Differences in the Effect of HIV Status on Motor and Pulmonary Function and Mobility Disability in Older Adults
    Brittney S. Lange‐Maia, Aron S. Buchman, Sue E. Leurgans, Melissa Lamar, Elizabeth B. Lynch, Kristine Mace Erlandson, Lisa Laverne Barnes · 2021 · Journal of Racial and Ethnic Health Disparities
  46. DM management in HIV patients: the adoption of population health management to transform the chronic management of HIV
    Guglielmo Pacileo, Verdiana Morando, Helen Banks, Lucia Ferrara, Anna Maria Cattelan, Roberto Luzzati, Vinicio Manfrin, Valeria D. Tozzi · 2022 · European Journal of Public Health
  47. HIV Infection and AIDS: The Present Status of Antiretroviral Therapy
    Vassilios A. Paparizos, Sofia Kourkounti · 2023 · Springer eBooks
  48. The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era
    Amanda Mocroft, H. J. Furrer, J. M. Miro, Peter Reiss, C. Mussini, Ole Kirk, Sophie Abgrall, S. Ayayi, B. Bartmeyer, D. Braun et al. · 2013 · Clinical Infectious Diseases
  49. Incidence of benign prostate hypertrophy in Danish men with and without HIV infection
    Magnus Glindvad Ahlström, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Jan Gerstoft, Niels Obel · 2015 · AIDS
  50. Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients
    Chiara Dentone, Antonio Di Biagio, Alessandro Cozzi‐Lepri, Daniela Fenoglio, Gilberto Filaci, Miriam Lichtner, Stefania C. Carrara, Andrea Giacometti, Laura Sighinolfi, Giulia Carla Marchetti et al. · 2018 · HIV Clinical Trials
  51. Role of Glutathione S-Transferase (GSTM1 and GSTT1) Genes Deletion in Susceptibility to HIV-1 Disease Progression
    Florencia Wendkuuni Djigma, Pegdwendé Abel Sorgho, Serge Théophile Soubeïga, Albert Théophane Yonli, Herman Karim Sombié, Isabelle Touwendpoulimdé Kiendrebeogo, Tégwindé Rébeca Compaore, Abdoul Karim Ouattara, Bapio V. J. T. Elvira Bazie, Bolni Marius Nagalo et al. · 2020 · Journal of Biosciences and Medicines
  52. The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
    Zohre Naderi, Arda Kiani, Majid Marjani, Esmaeil Mortaz, Fariba Ghorbani, Fatemeh Razavi, Atefeh Abedini · 2021 · International Journal of Mycobacteriology
  53. The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries – Euroguidelines in Central and Eastern Europe Network Group data
    Kerstin Kase, Agata Skrzat‐Klapaczyńska, Anna Vassilenko, Arjan Harxhi, Botond Lakatos, Gordana Dragović, David Jilich, Antonija Verhaz, Nina Yancheva, Florentina Dumitrescu et al. · 2020 · medRxiv
  54. Cellular and Soluble Immune Activation Markers in HIV-Infected Subjects
    Basile T. Siewe, ALAN L. LANDAY · 2018 · Springer eBooks
  55. Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands
    Marleen A. van Amsterdam, Sander van Assen, Herman G. Sprenger, Kasper R. Wilting, Ymkje Stienstra, Wouter F.W. Bierman · 2017 · PLoS ONE
  56. Cytogenetic changes in oral mucosal cells of human immunodeficiency virus-infected children and adolescents undergoing antiretroviral treatment
    Maria Esther Suarez Alpire, Daniel Vitor de Souza, Carolina Marquez da Costa Brites Masutti, Marcos Montani Caseiro, Daniel Araki Ribeiro · 2023 · Revista da Associação Médica Brasileira
  57. Dihydroartemisinin Inhibits T Cell Activation in People Living with HIV with Incomplete Immune Reconstitution In Vitro
    Yang Zhang, Jiahao Ji, Xiaodong Dou, Rui Wang, Hao Wu, Zhen Li, Tong Zhang · 2024 · Journal of Exploratory Research in Pharmacology
  58. Perspectives on Continuing Care, From Home Care to Long‐Term Care, for Older People Living With HIV: A Cross‐Sectional Study
    Jacqueline M. McMillan, Jessica Dalere, Farwa Naqvi, Vivian Ewa, Raynell Lang, Raman Brar, Katrina Milaney, Jeffrey Alexander Bakal, Hartmut B. Krentz, Patrick B. Quail et al. · 2025 · Health Science Reports
  59. Dolutegravir (DTG) + Lamivudine (3 TC) in Antiretroviral-Naive Adults With HIV With and Without Genotypic Resistance Testing Results: 96-Week Effectiveness and Tolerability of REDOLA Study
    Alfonso Cabello, Juan Carlos López Bernardo de Quirós, Álvaro Mena, Miguel Torralba, Luz Martín‐Carbonero, Ángela Gutiérrez, Jorge Vergas, Adriana Pinto, Francisco Tejerina, Esmeralda Palmier et al. · 2025 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  60. Advancing the course of HIV genomics research in Africa
    Francis Edem Agamah, Patrick B. Arbuthnot, Paulina Onvomaha Tindana, Nchangwi Syntia Munung, Mary Kasule, Anita Ghansah, Mosepele Mosepele, Tendani Gaolathe, Adeodata Kekitiinwa, Eunice Wambui Nduati et al. · 2025 · BMJ Global Health
  61. Awareness of organ donation among people living with HIV in Canada: a cross-sectional study
    Julia Nicholds, Michael Dans, Jonathan Benjamin Angel · 2025 · HIV Research & Clinical Practice
  62. RePrediction of chemical characteristics of individuals with HIV infection using an image processing-centric optimized deep learning-based CNN model
    Yusuf Alaca, Nursel Karaoğlan, Erdal Başaran, Yüksel Çelik · 2026 · Biomedical Signal Processing and Control
  63. Attention in HIV
    Schuyler D. Van Dyk, M Kathleen · 2015
  64. Inflammatory status hepatic enzymes and serum creatinine in HIV-, HIV+ and HIV-TB co-infected adult Central Africans
    Benjamin Longo‐Mbenza, Mokondjimobe, Kibokela Ndembe Dalida, Henri Joseph Parra, Martin Diatewa · 2012 · International Journal of General Medicine
  65. Cambios en las características clínico-epidemiológicas de los nuevos casos de infección por el VIH-1 en Castellón (España) y su repercusión en la presentación tardía (1987-2011)
    Carlos Mínguez‐Gallego, E.J. Vera-Remartínez, Mónica Albert-Coll, M. Concepción Roldán-Puchalt, Manuel Aguilar-Climent, Rosa E. Rovira-Ferrando, Jorge Andrés-Soler, Belen Roig-Espert, María Penadés-Vidal, Jorge Usó Blasco · 2014 · Enfermedades Infecciosas y Microbiología Clínica
  66. The Aging Skeleton: Differences Between HIV-Infected Patients and the Uninfected Aging Population
    Giovanni Guaraldi, Antonella Santoro, Ana Rita Domingues da Silva · 2012 · Clinical Reviews in Bone and Mineral Metabolism
  67. Drug treatment for adults with HIV infection
    Miriam Samuel, Alan Winston, B Peters · 2015 · BMJ
  68. Drug-drug interactions in ageing HIV-infected individuals
    S. Fasinu · 2012 · African Journal of Pharmacy and Pharmacology
  69. Non-ARV Prescriptions and Medication Burden among Commercially Insured U.S. HIV Patients
    Nana Koram, Vani X. Vannappagari, Sampson TJ, Catherine A. Panozzo · 2014 · Journal of Pharmaceutics and Drug Development
  70. Viral, Host and Therapeutic Factors Affecting T-cell Recovery in Virologically Controlled HIV Patients
    Carmela Pinnetti, Alessandra Bandera, Davide Mangioni, Andrea Gori · 2012 · Future Virology
  71. Morbidität und Mortalität der HIV-Infektion
    M Stöckle, Luigia Elzi, Jürgen Kurt Rockstroh, Manuel Battegay · 2012 · Der Internist
  72. HIV: A Chronic Condition
    Daniel D Zimmerman · 2015 · Journal of Insurance Medicine
  73. Altered Redox Regulation as Cofactor in Comorbidities and Accelerated Aging in HIV Infection Evolution and Antiretroviral Treatment
    Lizette Gil del Valle · 2014 · Epidemiology Open Access
  74. Functionally Defective High-Density Lipoproteins Are Related to Heightened T-Cell Activation in Vertically HIV-Infected Adolescents
    Talía Sainz, Adriana Ortega‐Hernández, Sergio Serrano Villar, María Luisa Navarro, Pablo Rojo, José Tomás Ramos, María José Mellado, Laura Díaz, Maria Alvarez, Vicente Estrada et al. · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  75. Human Immune-Deficiency Virus Associated Deep Vein Thrombosis Coexisting with Venous Ulcer
    Ekpe EE, Mabel Ino-Ekanem · 2014 · International Journal of Medical and Dental Sciences
  76. Prevalence of HIV in Hospitalized Patients with Venous Thrombosis of the Lower Limbs to the Abidjan Cardiological Institute
    Fatoumata Traore, K Bamba, F. Koffi, E. Soya, MARIE-PAULE BERNADETTE N'CHO-MOTTOH, Yves N’da Kouakou N’goran, Iklo Coulibaly · 2017 · World Journal of Cardiovascular Diseases
  77. Immune Senescence and Inflammaging in Neurological Diseases
    Pascale Baden, Silvia De Cicco, Cong Yu, Michela Deleidi · 2019 · Springer eBooks
  78. Understanding Immune Senescence, Exhaustion, and Immune Activation in HIV–Tuberculosis Coinfection
    Esaki Muthu Shankar, Alireza Saeidi, Ramachandran Vignesh, Vijayakumar Velu, Marie Larsson · 2017 · Springer eBooks
  79. Association of KIR haplotypes with propensity for developing chronic hepatitis B induced liver diseases (cirrhosis and hepatocellular carcinoma) and HIV-1 infection in a West African Cohort
    Djigma Florencia Wendkuuni, Pegdwendé Abel Sorgho, Marius Ayaovi Setor, Nagalo Bolni Marius, Lassina Traoré, Wendyam Marie Christelle Nadembega, Djénèba Ouermi, Yonli Albert Théophane, Jacques Simporè · 2020 · Annals of Molecular and Genetic Medicine
  80. Bone Biomarkers in HIV
    Mark Bloch, Giovanni Guaraldi · 2017 · Biomarkers in disease
  81. Understanding Immune Senescence, Exhaustion, and Immune Activation in HIV–Tuberculosis Coinfection
    Esaki Muthu Shankar, Alireza Saeidi, Ramachandran Vignesh, Vijayakumar Velu, Marie Larsson · 2019 · Springer eBooks
  82. Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial
    Talía Sainz, Inmaculada Casas, Mónica González-Esguevillas, Luis Escosa‐García, María Ángeles Muñoz‐Fernández, Luis Manuel Prieto, María José Gosalbes, Nuria Jiménez‐Hernández, José Tomás Ramos, María Luisa Navarro et al. · 2022 · Frontiers in Pediatrics
  83. An overview of the mechanisms of HIV-1 infection, latency, pathogenesis, and eradication strategies from the CNS
    Priya Tyagi, Mudit Tyagi · 2024 · Elsevier eBooks
  84. HIV Infections and Prevention in Women
    Anna Maya Powell · 2025 · Clinical Obstetrics & Gynecology
  85. Immunomodulatory biomaterials in HIV-1 infection prevention, control and treatment
    Jiaying Li, Huan Tang, Xiaoyi Zhou, Zijun Ni, Yuxin Liang, Xinyue Sun, Xun Zhuang · 2025 · Frontiers in Immunology
  86. Overview of antiretroviral therapy
    Susa Coffey, Paul A. Volberding · 2012 · Elsevier eBooks
  87. The occurrence and characteristics of pain in HIV-1 positive persons – A challenge in the aging population
    Marcin Kowalski, Ewa Firląg‐Burkacka, Andrzej Horban · 2015 · HIV & AIDS Review
  88. Changes in Biomarkers in HIV-1-Infected Treatment-Naive Patients Treated with Tenofovir DF/Emtricitabine plus Atazanavir/Ritonavir or Lopinavir/Ritonavir for 96 Weeks: The CASTLE Biomarker Substudy
    Graeme J Moyle, Hélène Hardy, Jonathan P. Uy, Neelanjana Ray, María Jesús Jiménez‐Expósito, Donnie McGrath, Edwin DeJesus · 2013 · Antiviral Therapy
  89. HIV, the Lung and Aging
    Lynn M. Schnapp, Kristina A. Crothers · 2015 · WORLD SCIENTIFIC eBooks
  90. HIV/Aids
    Armin Schafberger · 2010 · Public Health Forum
  91. Immunomodulatory properties of the HIV-1 Tat protein
    Francesco Nicoli · 2013
  92. Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411
    Alessia Uglietti, Renato Maserati · 2011 · Expert Opinion on Investigational Drugs
  93. Hepatitis B virus-associated hepatocellular carcinoma in South Africa: epidemiology and impact of HIV-1 co-infection and immune dysregulation
    Tongai Gibson Maponga · 2016 · SUNScholar (Stellenbosch University)
  94. Cellular and Soluble Immune Activation Markers in HIV-Infected Subjects
    Basile T. Siewe, ALAN L. LANDAY · 2015 · Springer eBooks
  95. The HIV response and global health
    Roger I. Glass, Wafaa M. El-Sadr, Eric Goosby, Linda E. Kupfer · 2019 · The Lancet
  96. The impact of comorbidity and clinical complexity on retention in HIV care
    Shiraze M. Bulsara · 2019 · OPUS - Open Publications of UTS Scholars (University of Technology Sydney)
  97. HIV infection: antiretroviral therapy
    Kathleen Squires, Christopher T. Miller · 2015 · Cambridge University Press eBooks
  98. Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4+ T-Cells by Decreasing Viral Release
    Augustine Fert, Jonathan Richard, Laurence Raymond Marchand, Delphine Planas, Jean‐Pierre Routy, Nicolas Chomont, Andrés Finzi, Petronela Ancuța · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  99. An Approach on HIV Infection
    Antonella Elisa Chesca, Tim Sandle · 2024 · Preprints.org
  100. Key Points in HIV Infection
    Antonella Elisa Chesca, Tim Sandle · 2024 · Preprints.org